Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)
Clinical trial NCT00358670 · TERMINATED
Trial details
- NCT number
- NCT00358670
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-01-01
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.